
San Francisco Chronicle (12.09.05) - Friday, December 09, 2005
Sabin Russell
The Food and Drug Administration approved the test for professional use in March 2004 and is considering an application by its maker, Orasure Technologies, to allow over- the-counter sales.
Klausner said City Clinic, the department's main site for STD and HIV testing, no longer uses the oral test, though he added, "I am not ready to discard this citywide."
Joanna Rinaldi, deputy director of the AIDS Health Project in San Francisco, said her program stopped using the oral test three weeks ago after logging 28 false positives since the spring. "We just couldn't have more folks be distressed," she said, noting there have been no more false positives since AHP returned to finger-stick blood testing.
In response to the problem, the California Department of Health Services is conducting a statewide survey. While the problem has not yet turned up in other cities, results from Los Angeles are not in. San Francisco has forwarded its findings to CDC, Orasure and the state Office of AIDS.
"We have not lost confidence in the test, but we still have to be vigilant about it," said Deanne Sykes, a research scientist for the state Office of AIDS. She does not believe the problem stems from how San Francisco clinicians are conducting the test, as they are among the world's most experienced HIV testers. One theory is that there is something about the San Francisco patients, perhaps a high prevalence of hepatitis, that causes a "cross reaction" with the HIV test.
Orasure CEO Douglas Michels expressed "every confidence that the test is reliable and accurate" and said no similar problems have been reported outside San Francisco.
051209
AD052489
Copyright © 2005 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.